Essential role for prolyl hydroxylase domain protein 2 in oxygen Homeostasis of the adult vascular system

被引:206
作者
Takeda, Kotaro [1 ]
Cowan, Ann [1 ]
Fong, Guo-Hua [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Ctr Vasc Biol,Ctr Biomed Imaging Technol, Dept Cell Biol, Farmington, CT 06030 USA
关键词
angiogenesis; hypoxia; cardiovascular system;
D O I
10.1161/CIRCULATIONAHA.107.701516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Prolyl hydroxylase domain ( PHD) proteins, including PHD1, PHD2, and PHD3, mediate oxygen- dependent degradation of hypoxia- inducible factor ( HIF)- alpha subunits. Although angiogenic roles of hypoxia- inducible factors are well known, the roles of PHDs in the vascular system remain to be established. Methods and Results - We evaluated angiogenic phenotypes in mice carrying targeted disruptions in genes encoding different PHD isoforms. Although Phd1 -/- and Phd3 -/- mice did not display apparent angiogenic defects, broadspectrum conditional knockout of Phd2 led to hyperactive angiogenesis and angiectasia. Blood vessels in PHD2deficient mice were highly perfusable. Furthermore, examination of medium- sized vessels in subendocardial layer in the heart demonstrated successful recruitment of vascular smooth muscle cells. Surprisingly, increased vascular growth was independent of local efficiency of Phd2 disruption. Mice carrying significant Phd2 disruption in multiple organs, including the liver, heart, kidney, and lung, displayed excessive vascular growth not only in these organs but also in the brain, where Phd2 disruption was very inefficient. More surprisingly, increased accumulation of hypoxia- inducible factor- 1 alpha and angiectasia in the liver were not accompanied by corresponding increases in hepatic expression of Vegfa or angiopoietin- 1. However, the serum vascular endothelial growth factor- A level was significantly increased in PHD2- deficient mice. Conclusions - PHD2, but not PHD1 and PHD3, is a major negative regulator for vascular growth in adult mice. Increased angiogenesis in PHD2- deficient mice may be mediated by a novel systemic mechanism.
引用
收藏
页码:774 / 781
页数:8
相关论文
共 40 条
[1]   Stabilization of wild-type p53 by hypoxia-inducible factor 1α [J].
An, WG ;
Kanekal, M ;
Simon, MC ;
Maltepe, E ;
Blagosklonny, MV ;
Neckers, LM .
NATURE, 1998, 392 (6674) :405-408
[2]   Stimulation of HIF-1α, HIF-2α, and VEGF by prolyl 4-hydroxylase inhibition in human lung endothelial and epithelial cells [J].
Asikainen, TM ;
Ahmad, A ;
Schneider, BK ;
Ho, WB ;
Arend, M ;
Brenner, M ;
Günzler, V ;
White, CW .
FREE RADICAL BIOLOGY AND MEDICINE, 2005, 38 (08) :1002-1013
[3]   HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia [J].
Berra, E ;
Benizri, E ;
Ginouvès, A ;
Volmat, V ;
Roux, D ;
Pouysségur, J .
EMBO JOURNAL, 2003, 22 (16) :4082-4090
[4]   A conserved family of prolyl-4-hydroxylases that modify HIF [J].
Bruick, RK ;
McKnight, SL .
SCIENCE, 2001, 294 (5545) :1337-1340
[5]   Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis [J].
Carmeliet, P ;
Dor, Y ;
Herbert, JM ;
Fukumura, D ;
Brusselmans, K ;
Dewerchin, M ;
Neeman, M ;
Bono, F ;
Abramovitch, R ;
Maxwell, P ;
Koch, CJ ;
Ratcliffe, P ;
Moons, L ;
Jain, RK ;
Collen, D ;
Keshet, E .
NATURE, 1998, 394 (6692) :485-490
[6]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[7]   Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1α [J].
Elson, DA ;
Thurston, G ;
Huang, LE ;
Ginzinger, DG ;
McDonald, DM ;
Johnson, RS ;
Arbeit, JM .
GENES & DEVELOPMENT, 2001, 15 (19) :2520-2532
[8]   C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation [J].
Epstein, ACR ;
Gleadle, JM ;
McNeill, LA ;
Hewitson, KS ;
O'Rourke, J ;
Mole, DR ;
Mukherji, M ;
Metzen, E ;
Wilson, MI ;
Dhanda, A ;
Tian, YM ;
Masson, N ;
Hamilton, DL ;
Jaakkola, P ;
Barstead, R ;
Hodgkin, J ;
Maxwell, PH ;
Pugh, CW ;
Schofield, CJ ;
Ratcliffe, PJ .
CELL, 2001, 107 (01) :43-54
[9]  
Erez N, 2003, CANCER RES, V63, P8777
[10]  
Forsythe JA, 1996, MOL CELL BIOL, V16, P4604